Gene Therapy for Acute Respiratory Distress Syndrome

Abstract excerpt

Acute respiratory distress syndrome (ARDS) is a devastating clinical syndrome that leads to acute respiratory failure and accounts for over 70,000 deaths per year in the United States alone, even prior to the COVID-19 pandemic. While its molecular details have been teased apart and its pathophysiology largely established over the past 30 years, relatively few pharmacological advances in treatment have been made...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neonatal Respiratory Health Research
• Share to RNA Interference and Gene Delivery
• Share to Virus-based gene therapy research